Literature DB >> 2417899

Studies of developmental abnormalities at the molecular level of mouse embryos homozygous for the t12 lethal mutation.

M Nozaki, Y Iwakura, A Matsushiro.   

Abstract

Embryos obtained by crossing heterozygous t12 mutant mice were labeled metabolically with 14C-amino acids at the mid-morula stage, and the protein pattern of single embryos was examined by two-dimensional polyacrylamide gel electrophoresis. After labeling, the morphology was still normal. The genotypes of the embryos could be identified by the allelic forms of Tcp-1 (p63/6.9) protein on the gel. In t12/t12 embryos, the bulk of syntheses of macromolecules such as proteins and RNAs [poly(A)+, as well as poly(A)-RNA] was normal, however, syntheses of several proteins were markedly reduced. Some of these proteins present in reduced amounts appeared to be components of cytokeratin-type intermediate filaments (endo A and endo B), judging from their insolubility in non-ionic detergent, their appearance in the mid-morula stage, their location in trophectodermal cells, and their electrophoretic mobilities. These observations suggest that mechanisms for the induction of the intermediate filament proteins are defective in embryos homozygous for the t12 mutation. Possible relationships between the morphological abnormalities of the embryos and their defective synthesis of intermediate filaments are discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2417899     DOI: 10.1016/0012-1606(86)90104-1

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  2 in total

1.  The promoter of the endo A cytokeratin gene is activated by a 3' downstream enhancer.

Authors:  Y Takemoto; Y Fujimura; M Matsumoto; Y Tamai; T Morita; A Matsushiro; M Nozaki
Journal:  Nucleic Acids Res       Date:  1991-05-25       Impact factor: 16.971

2.  Escape from genomic imprinting at the mouse T-associated maternal effect (Tme) locus.

Authors:  J Y Tsai; L M Silver
Journal:  Genetics       Date:  1991-12       Impact factor: 4.562

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.